PA
Profund Advisors Portfolio holdings
AUM
$2.78B
1-Year Return
29.53%
This Quarter Return
+15.99%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$2.57B
AUM Growth
+$240M
(+10%)
Cap. Flow
+$2.26M
Cap. Flow
% of AUM
0.09%
Top 10 Holdings %
Top 10 Hldgs %
34.11%
Holding
1,211
New
84
Increased
525
Reduced
539
Closed
63
Top Buys
| 1 |
NVIDIA
NVDA
|
$23.5M |
| 2 |
Linde
LIN
|
$16.4M |
| 3 |
Broadcom
AVGO
|
$3.16M |
| 4 |
Advanced Micro Devices
AMD
|
$2.67M |
| 5 |
Qualcomm
QCOM
|
$1.54M |
Top Sells
| 1 |
Exxon Mobil
XOM
|
$6.7M |
| 2 |
Microsoft
MSFT
|
$5.59M |
| 3 |
Chevron
CVX
|
$4.56M |
| 4 |
Meta Platforms (Facebook)
META
|
$4.45M |
| 5 |
Viking Therapeutics
VKTX
|
$3.77M |
Sector Composition
| 1 | Technology | 42.5% |
| 2 | Healthcare | 12.67% |
| 3 | Consumer Discretionary | 11.07% |
| 4 | Communication Services | 9.14% |
| 5 | Financials | 5.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Public Service Enterprise Group
PEG
$40.5B
| $1.24M | 0.05% |
18,597
-1,545
| -8% | -$103K |
|
302
Targa Resources
TRGP
$34.9B
| $1.24M | 0.05% |
11,044
-2,941
| -21% | -$329K |
|
303
Keros Therapeutics
KROS
$633M
| $1.24M | 0.05% |
18,661
+7,814
| +72% | +$517K |
|
304
Novavax
NVAX
$1.28B
| $1.23M | 0.05% |
257,058
+407
| +0.2% | +$1.95K |
|
305
BioCryst Pharmaceuticals
BCRX
$1.74B
| $1.23M | 0.05% |
241,872
+86,483
| +56% | +$439K |
|
306
General Motors
GM
$55.5B
| $1.21M | 0.05% |
26,668
-5,094
| -16% | -$231K |
|
|
MORF
307
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $1.21M | 0.05% |
34,271
+1,388
| +4% | +$48.9K |
|
308
Ardelyx
ARDX
$1.57B
| $1.2M | 0.05% |
164,858
-57,790
| -26% | -$422K |
|
309
Equinix
EQIX
$75.7B
| $1.2M | 0.05% |
1,458
-131
| -8% | -$108K |
|
310
CRISPR Therapeutics
CRSP
$4.99B
| $1.2M | 0.05% |
17,596
-4,355
| -20% | -$297K |
|
311
Ford
F
$46.7B
| $1.2M | 0.05% |
90,147
-1,056
| -1% | -$14K |
|
312
Illinois Tool Works
ITW
$77.6B
| $1.19M | 0.05% |
4,450
+797
| +22% | +$214K |
|
313
Parker-Hannifin
PH
$96.1B
| $1.19M | 0.05% |
2,142
+501
| +31% | +$278K |
|
314
US Bancorp
USB
$75.9B
| $1.19M | 0.05% |
26,608
-1,208
| -4% | -$54K |
|
315
Dropbox
DBX
$8.06B
| $1.19M | 0.05% |
48,857
+7,861
| +19% | +$191K |
|
316
KE Holdings
BEKE
$22.4B
| $1.19M | 0.05% |
86,330
-16,585
| -16% | -$228K |
|
317
D.R. Horton
DHI
$54.2B
| $1.18M | 0.05% |
7,183
+764
| +12% | +$126K |
|
318
CME Group
CME
$94.4B
| $1.18M | 0.05% |
5,486
+532
| +11% | +$115K |
|
319
Vera Therapeutics
VERA
$1.54B
| $1.18M | 0.05% |
27,346
-423
| -2% | -$18.2K |
|
320
Intercontinental Exchange
ICE
$99.8B
| $1.17M | 0.05% |
8,524
+260
| +3% | +$35.7K |
|
321
Consolidated Edison
ED
$35.4B
| $1.17M | 0.05% |
12,880
-1,072
| -8% | -$97.3K |
|
322
Prothena Corp
PRTA
$460M
| $1.16M | 0.05% |
46,878
+13,124
| +39% | +$325K |
|
323
TransDigm Group
TDG
$71.6B
| $1.16M | 0.05% |
941
+260
| +38% | +$320K |
|
324
Akero Therapeutics
AKRO
$3.58B
| $1.16M | 0.05% |
45,870
-26,674
| -37% | -$674K |
|
325
Motorola Solutions
MSI
$79.8B
| $1.15M | 0.04% |
3,241
-149
| -4% | -$52.9K |
|